23.09.2011 • News

Enzon Pharmaceuticals To Cut Nearly Half Of Its Workforce

 

Enzon Pharmaceuticals Thursday announced a 48% reduction in employees to more closely align its resources with the company's research and development activities.

Results for the ongoing quarter would include a charge related to the workforce reduction.

The reduction in force will reduce the number of employees by approximately 48%, to a total of 47, effective June 2012.

Enzon expects the reduction in force to result in approximately $6.0 million in reduced annualized operating expenses once the plan is fully implemented by the second quarter of 2012.

The Piscataway, New Jersey-headquartered company also expects to incur a charge in the third quarter of 2011 of approximately $3.0 million related to the reduction.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.